Trial intelligence / Profile preview

Low-dose oral isotretinoin for acne vulgaris

IRCT2015061722780N1Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of isotretinoin in acne vulgaris, sponsored by Isfahan University of Medical Sciences. Started Sep 2014; status: completed.

02

Drugs

isotretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on IRCT2015061722780N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015061722780N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call